Acute Lymphoblastic Leukemia (ALL): Clinical Trials

2 trials for Acute Lymphoblastic Leukemia (ALL), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Unknown 1

Follow Acute Lymphoblastic Leukemia (ALL): new trials by email Literature Review of Acute Lymphoblastic Leukemia (ALL) trials Research Report on Acute Lymphoblastic Leukemia (ALL)

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study
Nilotinib - Chronic Myelogenous Leukemia (CML), Metastatic Gastrointestinal Stromal Tumors (GIST)
Phase 4CompletedNovartis Pharmaceuticals572013-03-292024-02-08
Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study
Prednisolone, Dexamethasone, L-Asparaginase - Acute Lymphoblastic Leukemia (ALL)
Phase 4UnknownNational University Hospital, Singapore5002008-10-012016-09-30

Narrower conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Gastrointestinal Stromal Tumors (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Piebaldism (1)

Broader conditions

Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Leukemia (2)  ·  Leukemia, Lymphoid (2)  ·  Lymphatic Diseases (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Albinism (1)  ·  Amino Acid Metabolism, Inborn Errors (1)  ·  Bone Marrow Diseases (1)  ·  Chronic Disease (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)

Interventions

Asparaginase (1)  ·  Cyclophosphamide (1)  ·  Cytarabine (1)  ·  Daunorubicin (1)  ·  Dexamethasone (1)  ·  Doxorubicin (1)  ·  Imatinib Mesylate (1)  ·  Mercaptopurine (1)  ·  Methotrexate (1)  ·  Prednisolone (1)  ·  Thioguanine (1)  ·  Vincristine (1)  ·  fludarabine (1)  ·  nilotinib (1)

Sponsors

National University Hospital, Singapore (1)  ·  Novartis Pharmaceuticals (1)

Countries

Singapore (2)  ·  Austria (1)  ·  Canada (1)  ·  France (1)  ·  Hong Kong (1)  ·  Hungary (1)  ·  Israel (1)  ·  Italy (1)  ·  Malaysia (1)  ·  Netherlands (1)  ·  Russia (1)  ·  Slovakia (1)  ·  South Korea (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Allen Yeoh, MBBS (1)

Results publications

PMID 30044693, PMID 37276496